|
58
|
256
|
4b0aA |
The high-resolution structure of ytbp-ytaf1 identifies conserved and competing interaction surfaces in transcriptional activation |
|
100
|
263
|
4bcrA |
Structure of pparalpha in complex with wy14643 |
|
161
|
563
|
4bhwA |
Structural basis for autoinhibition of the acetyltransferase activity of p300 |
|
39
|
115
|
4a9kA |
Bromodomain of human crebbp with n-(4-hydroxyphenyl)acetamide |
|
84
|
310
|
5iybM |
Human core-pic in the open state |
|
72
|
310
|
5iy6M |
Human holo-pic in the closed state |
|
2
|
11
|
3vn2C |
Crystal structure of ppargamma complexed with telmisartan |
|
3
|
11
|
3v9yB |
Crystal structure of the ppargamma-lbd complexed with a cercosporamide derivative modulator |
|
22
|
112
|
3v43A |
Crystal structure of moz |
|
48
|
125
|
3uv4A |
Crystal structure of the second bromodomain of human transcription initiation factor tfiid subunit 1 (taf1) |
|
2
|
9
|
3uu7F |
Crystal structure of hera-lbd (y537s) in complex with bisphenol-a |
|
2
|
9
|
3uudC |
Crystal structure of hera-lbd (y537s) in complex with estradiol |
|
2
|
9
|
3uuaF |
Crystal structure of hera-lbd (y537s) in complex with bisphenol-af |
|
100
|
255
|
3uv5A |
Crystal structure of the tandem bromodomains of human transcription initiation factor tfiid subunit 1 (taf1) |
|
79
|
276
|
3to7A |
Crystal structure of yeast esa1 hat domain bound to coenzyme a with active site lysine acetylated |
|
80
|
276
|
3to6A |
Crystal structure of yeast esa1 hat domain complexed with h4k16coa bisubstrate inhibitor |
|
83
|
276
|
3to9A |
Crystal structure of yeast esa1 e338q hat domain bound to coenzyme a with active site lysine acetylated |
|
73
|
271
|
3toaA |
Human mof crystal structure with active site lysine partially acetylated |
|
79
|
271
|
3tobA |
Human mof e350q crystal structure with active site lysine partially acetylated |
|
44
|
113
|
3t92A |
Crystal structure of the taz2:c/ebpepsilon-tad chimera protein |
|
2
|
8
|
3t03C |
Crystal structure of ppar gamma ligand binding domain in complex with a novel partial agonist gq-16 |
|
2
|
11
|
3rutB |
Fxr with src1 and gsk359 |
|
2
|
11
|
3ruuB |
Fxr with src1 and gsk237 |
|
3
|
11
|
3rvfB |
Fxr with src1 and gsk2034 |
|
92
|
290
|
3r8dA |
Activation of the human nuclear xenobiotic receptor pxr by the reverse transcriptase-targeted anti-hiv drug pnu-142721 |
|
3
|
11
|
5ycnB |
Human ppargamma ligand binding domain complexed with lobeglitazone |
|
4
|
15
|
5x0rC |
Crystal structure of pxr lbd complexed with sjb7 |
|
2
|
9
|
5x8wB |
Crystal structure of the mutant human ror gamma ligand binding domain. |
|
81
|
286
|
5wciA |
Human myst histone acetyltransferase 1 |
|
41
|
116
|
5w0qA |
Crebbp bromodomain in complex with cpd17 (n,2,7-trimethyl-2,3-dihydro-4h-benzo[b][1,4]oxazine-4-carboxamide) |
|
18
|
50
|
5vjiA |
Crystal structure of the clock transcription domain exon19 in complex with a repressor |
|
43
|
114
|
5w0fA |
Crebbp bromodomain in complex with cpd3 ((s)-1-(3-(6-(1-methyl-1h-pyrazol-4-yl)-3,4-dihydroquinolin-1(2h)-yl)-1-(tetrahydrofuran-3-yl)-1,4,6,7-tetrahydro-5h-pyrazolo[4,3-c]pyridin-5-yl)ethan-1-one) |
|
38
|
114
|
5w0iA |
Crebbp bromodomain in complex with cpd8 (1-(3-(7-(difluoromethyl)-6-(1-methyl-1h-pyrazol-4-yl)-3,4-dihydroquinolin-1(2h)-yl)-1-(tetrahydrofuran-3-yl)-1,4,6,7-tetrahydro-5h-pyrazolo[4,3-c]pyridin-5-yl)ethan-1-one) |
|
25
|
111
|
5u2jA |
Morf double phd finger (dpf) in complex with histone h3k14bu |
|
15
|
87
|
5u4kA |
Nmr structure of the complex between the kix domain of cbp and the transactivation domain 1 of p65 |
|
46
|
165
|
5trlA |
Crystal structure of human gcn5 histone acetyltransferase domain |
|
45
|
165
|
5trmA |
Crystal structure of human gcn5 histone acetyltransferase domain |
|
35
|
106
|
5tpxA |
Bromodomain from plasmodium faciparum gcn5, complexed with compound |
|
41
|
119
|
5tb6A |
Structure of bromodomain of crebbp with a pyrazolo[4,3-c]pyridin fragment |
|
3
|
11
|
5q12B |
Ligand binding to farnesoid-x-receptor |
|
3
|
11
|
5q0jB |
Ligand binding to farnesoid-x-receptor |
|
38
|
85
|
5svhA |
Crystal structure of the kix domain of cbp in complex with a mll/c-myb chimera |
|
2
|
11
|
5q1dB |
Ligand binding to farnesoid-x-receptor |
|
2
|
9
|
5q1gB |
Ligand binding to farnesoid-x-receptor |
|
3
|
11
|
5q1eB |
Ligand binding to farnesoid-x-receptor |
|
3
|
12
|
5q11B |
Ligand binding to farnesoid-x-receptor |
|
3
|
11
|
5q15B |
Ligand binding to farnesoid-x-receptor |
|
3
|
13
|
5q0xB |
Ligand binding to farnesoid-x-receptor |
|
3
|
12
|
5q18B |
Ligand binding to farnesoid-x-receptor |
|
3
|
12
|
5q0uB |
Ligand binding to farnesoid-x-receptor |
